Ocular manifestations in moderate-to-severe psoriasis in India: A prospective observational study
- PMID: 36018114
- PMCID: PMC9675526
- DOI: 10.4103/ijo.IJO_551_22
Ocular manifestations in moderate-to-severe psoriasis in India: A prospective observational study
Abstract
Purpose: Ocular manifestations in psoriasis are due to direct eye involvement with psoriatic plaques or psoriasis-related, immune-mediated inflammatory processes. The commonly reported pathologies are blepharitis, conjunctivitis, keratitis, dry eyes, and uveitis. Limited data is available on the ocular findings in psoriasis patients in India. In this study, we evaluated various ocular changes associated with moderate-to-severe psoriasis.
Methods: In this prospective cohort study, treatment-naive psoriasis patients with Psoriasis Area Severity Index (PASI) score of more than 10 were included. The Ocular Surface Disease Index (OSDI) score, Schirmer's score, tear film breakup time (TBUT), corneal and conjunctival staining score, and meibomian gland dysfunction score were noted. All these parameters were re-evaluated at 8 weeks of follow-up after systemic treatment.
Results: Sixty-eight patients were enrolled in the study. The most common ocular pathologies observed in this study were tarsal hyperemia and anterior blepharitis in 128 (94.1%) and 64 (47%) eyes, respectively. Mild, moderate, and severe dry eyes were seen in 26 (19.1%), 14 (10.2%), and 34 (25%) eyes, respectively. Thirty-nine (57.3%) patients complained of significant difficulty watching television or digital screen. In 21 patients evaluated on follow-up at 8 weeks, cornea and conjunctiva's ocular surface staining score increased and TBUT decreased significantly.
Conclusion: The most common ocular pathologies observed in this study were anterior blepharitis and moderate dry eye, which significantly affected most patients' daily routines. Screening patients with greater severity of psoriasis would help in early management of such problems.
Keywords: Dry Eyes; Schirmer's; ocular manifestation; psoriasis; tear film breakup time.
Conflict of interest statement
None
Figures
Comment in
-
Commentary: A clinician should know about systemic psoriasis and eye.Indian J Ophthalmol. 2022 Sep;70(9):3332-3334. doi: 10.4103/ijo.IJO_1547_22. Indian J Ophthalmol. 2022. PMID: 36018115 Free PMC article. No abstract available.
Similar articles
-
An observational study on ocular manifestations in patients of psoriasis in a tertiary care hospital in western India.Med J Armed Forces India. 2022 Sep;78(Suppl 1):S186-S193. doi: 10.1016/j.mjafi.2020.12.019. Epub 2021 Mar 26. Med J Armed Forces India. 2022. PMID: 36147389 Free PMC article.
-
Effects of radiation therapy on the meibomian glands and dry eye in patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma.BMC Ophthalmol. 2020 Jan 13;20(1):24. doi: 10.1186/s12886-019-1301-0. BMC Ophthalmol. 2020. PMID: 31931766 Free PMC article.
-
Ocular Surface Diseases in Patients With Diabetes.Cureus. 2022 Mar 22;14(3):e23401. doi: 10.7759/cureus.23401. eCollection 2022 Mar. Cureus. 2022. PMID: 35495002 Free PMC article.
-
Prospective evaluation of a new intense pulsed light, thermaeye plus, in the treatment of dry eye disease due to meibomian gland dysfunction.J Optom. 2021 Apr-Jun;14(2):103-113. doi: 10.1016/j.optom.2020.08.009. Epub 2020 Oct 26. J Optom. 2021. PMID: 33121905 Free PMC article. Review.
-
[Novel current and future therapy options for treatment of dry eye disease].Ophthalmologe. 2018 Feb;115(2):100-106. doi: 10.1007/s00347-017-0608-6. Ophthalmologe. 2018. PMID: 29134276 Review. German.
Cited by
-
Ocular complications in psoriatic patients: a systematic review and meta-analysis.J Ophthalmic Inflamm Infect. 2025 Mar 17;15(1):29. doi: 10.1186/s12348-025-00486-6. J Ophthalmic Inflamm Infect. 2025. PMID: 40097897 Free PMC article.
-
A Comprehensive Review of Ocular Manifestations in Systemic Diseases.Cureus. 2024 Jul 29;16(7):e65693. doi: 10.7759/cureus.65693. eCollection 2024 Jul. Cureus. 2024. PMID: 39211636 Free PMC article. Review.
-
Commentary: A clinician should know about systemic psoriasis and eye.Indian J Ophthalmol. 2022 Sep;70(9):3332-3334. doi: 10.4103/ijo.IJO_1547_22. Indian J Ophthalmol. 2022. PMID: 36018115 Free PMC article. No abstract available.
-
Elevated Serum Levels of Osteopontin in Patients with Psoriasis: Is It Associated with Ocular Comorbidities?Dermatol Pract Concept. 2024 Oct 30;14(4):e2024226. doi: 10.5826/dpc.1404a226. Dermatol Pract Concept. 2024. PMID: 39652965 Free PMC article.
-
Ocular complications in adults with psoriasis: a cross-sectional study in a referral center in Brazil.Int Ophthalmol. 2024 May 5;44(1):215. doi: 10.1007/s10792-024-03147-0. Int Ophthalmol. 2024. PMID: 38705919 Free PMC article.
References
-
- Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet. 2007;370:263–71. - PubMed
-
- Kilic B, Dogan U, Parlak AH, Goksugur N, Polat M, Serin D, et al. Ocular findings in patients with psoriasis:Ocular findings in psoriasis. Int J Dermatol. 2013;52:554–9. - PubMed
-
- Campanati A, Neri P, Giuliodori K, Arapi I, Carbonari G, Borioni E, et al. Psoriasis beyond the skin surface:A pilot study on the ocular involvement. Int Ophthalmol. 2015;35:331–40. - PubMed
-
- Demerdjieva Z, Mazhdrakova I, Tsankov N. Ocular changes in patients with psoriasis. Clin Dermatol. 2019;37:663–7. - PubMed
-
- Demirci G, Erdur SK, Aydin R, Balevi A, Eliacik M, Ozsutcu M, et al. Tear osmolarity and ocular surface parameters in patients with psoriasis. Arq Bras Oftalmol. 2017;80:1–3. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical